PPCB

Propanc Biopharma, Inc. Common Stock

NASDAQ: PPCB · HEALTHCARE · BIOTECHNOLOGY

$1.84

-12.80% today

Updated 2026-10-30

Market cap

$4.29M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-17.62

Dividend yield

—

52W range

$0 – $43

Volume

2.3M

Market cap

$4.29M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-17.62

Dividend yield

—

52W range

$0 – $43

Volume

2.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$1.52

-17.39%

12-Month target

$354.35

+19158.15%

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.05x — low leverage

Risks

- Thin margins at 0.00%

- Negative free cash flow $-1.70M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$0.00	$0.00	$0.00	—	—
Net income	$-2.66M	$-1.82M	$-58.92M	$-18.86M	$-4.57M
EPS	—	—	—	—	$-17.62
Free cash flow	$-1.11M	$-935120.00	$-405170.00	$-5.69M	$-1.70M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PPCB	$4.29M	26	4.3	3.0	5.0	7.3	—	Avoid
LLY	$1.26T	74	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$657.68B	54	4.7	8.5	2.7	5.5	-89.35%	Buy
ABBV	$521.11B	77	6.7	9.0	4.0	5.0	-88.02%	Strong Buy
MRK	$368.89B	44	3.3	6.5	2.0	5.0	-76.61%	Hold
UNH	$365.29B	62	6.7	6.0	4.7	5.5	-24.78%	Buy

Smart narrative

Propanc Biopharma, Inc. Common Stock trades at $1.84. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score.

Frequently asked questions

What is Propanc Biopharma, Inc. Common Stock's stock price?

Propanc Biopharma, Inc. Common Stock (PPCB) trades at $1.84.

Is Propanc Biopharma, Inc. Common Stock overvalued?

Propanc Biopharma, Inc. Common Stock carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Propanc Biopharma, Inc. Common Stock (PPCB)?

The 12-month analyst consensus target is $1.52, about 17.4% below the current $1.84. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-127.00%

Beta3.33

50D MA$0.91

200D MA$3.16

Shares out0.01B

Float0.01B

Short ratio—

Avg volume2.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PPCB vs LLY →PPCB vs JNJ →PPCB vs ABBV →Stock screener →